Who is the CEO of Northwest Biotherapeutics, Inc.?

The CEO of Northwest Biotherapeutics, Inc. is Linda F. Powers.

What industry does Northwest Biotherapeutics, Inc. belong to?

Northwest Biotherapeutics, Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Northwest Biotherapeutics, Inc. headquartered?

Northwest Biotherapeutics, Inc. is headquartered at 4800 Montgomery Lane, Bethesda, MD, 20814, US.

What is the IPO date of Northwest Biotherapeutics, Inc.?

Northwest Biotherapeutics, Inc. went public on December 14, 2001.

How many employees does Northwest Biotherapeutics, Inc. have?

Northwest Biotherapeutics, Inc. has approximately 25 full-time employees.

Northwest Biotherapeutics, Inc.

NWBO•PNK

Healthcare

Biotechnology

$0.26

$0.005(2.12%)

Northwest Biotherapeutics, Inc. (NWBO) Company Profile & Overview

Explore Northwest Biotherapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Northwest Biotherapeutics, Inc. (NWBO) Company Profile & Overview

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

SectorHealthcare

IndustryBiotechnology

CEOLinda F. Powers

Contact Information

https://www.nwbio.com

240 497 9024

4800 Montgomery Lane, Bethesda, MD, 20814

Company Facts

25 Employees

IPO DateDec 14, 2001

CountryUS

Actively Trading

Frequently Asked Questions

;